Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
PMLiVE
7h
Biogen’s higher dose spinal muscular atrophy regimen accepted for review by EMA/FDA
Biogen has announced that the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) have started ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Fed holds rates steady
Rescinds freeze on grants
Los Angeles wildfire updates
Eagles fan dies
Lay's potato chips recall
Crowd crush at Kumbh Mela
OK school citizenship rule
Denver schools face probe
FAA authorized NJ drones
Pilot safe after F-35 crash
CO military base for ICE use
ICC sanctions bill blocked
Win special primary in FL
Announces deal with Visa
To get own room in museum
Sudden movement probe
Announces ChatGPT Gov
Ticks closer to catastrophe
Security detail revoked
Inspects nuclear facility
Approved for kidney disease
Email privacy lawsuit filed
2023 derailment settlement
Recalls chicken nuggets
Frontier makes second bid
Senate confirmation hearing
To recall 290K+ vehicles
Related topics
Biogen
Food and Drug Administration
Spinal muscular atrophy
European Medicines Agency
Feedback